SpringWorks Therapeutics, Inc.

NasdaqGS:SWTX 株式レポート

時価総額:US$2.9b

SpringWorks Therapeutics 将来の成長

Future 基準チェック /56

SpringWorks Therapeuticsは、70%と44.7%でそれぞれ年率70%で利益と収益が成長すると予測される一方、EPSはgrowで69.9%年率。

主要情報

70.0%

収益成長率

69.9%

EPS成長率

Biotechs 収益成長28.3%
収益成長率44.7%
将来の株主資本利益率n/a
アナリストカバレッジ

Good

最終更新日20 Nov 2024

今後の成長に関する最新情報

Here's What Analysts Are Forecasting For SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Results

Nov 15
Here's What Analysts Are Forecasting For SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Results

Recent updates

Here's What Analysts Are Forecasting For SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Results

Nov 15
Here's What Analysts Are Forecasting For SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Results

SpringWorks Therapeutics Merits A Speculative Buy

Nov 04

SpringWorks Therapeutics: Rising On A Strong Post-Launch Quarter, Now Justified As A Buy

Aug 07

Need To Know: Analysts Are Much More Bullish On SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Revenues

May 11
Need To Know: Analysts Are Much More Bullish On SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Revenues

We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

May 03
We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

SpringWorks Therapeutics: Newly Commercial Stage, Fully Valued Biotech Means Steer Clear

Apr 25

SpringWorks Therapeutics: Multiple Opportunities, But No Sure-Fire Winners

Apr 19

We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

Sep 20
We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

We're Not Very Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Rate

Jun 07
We're Not Very Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Rate

We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

Feb 22
We Think SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation

Nov 09
Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation

SpringWorks drops 21% as Allogene drops lead asset in combination study

Aug 10

SpringWorks Therapeutics GAAP EPS of -$1.41 misses by $0.15

Aug 04

Sizing Up SpringWorks Therapeutics

Jul 20

Will SpringWorks Therapeutics (NASDAQ:SWTX) Spend Its Cash Wisely?

Jun 06
Will SpringWorks Therapeutics (NASDAQ:SWTX) Spend Its Cash Wisely?

SpringWorks Therapeutics: Rating Buy Ahead Of Mid-Year Data Releases

May 02

Companies Like SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Invest In Growth

Dec 30
Companies Like SpringWorks Therapeutics (NASDAQ:SWTX) Can Afford To Invest In Growth

SpringWorks Is A Biotech To Watch With Several Partnerships And Solid Drug Pipeline

Dec 14

SpringWorks Therapeutics (NASDAQ:SWTX) Is In A Strong Position To Grow Its Business

Sep 15
SpringWorks Therapeutics (NASDAQ:SWTX) Is In A Strong Position To Grow Its Business

業績と収益の成長予測

NasdaqGS:SWTX - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/2026596-25N/A634
12/31/2025355-14116-148
12/31/2024188-228-161-918
9/30/2024135-275-221-209N/A
6/30/202486-301-248-234N/A
3/31/202426-339-245-240N/A
12/31/20235-325-230-223N/A
9/30/2023N/A-305-226-214N/A
6/30/2023N/A-298-195-183N/A
3/31/2023N/A-289-185-175N/A
12/31/2022N/A-277-172-162N/A
9/30/2022N/A-259-164-154N/A
6/30/2022N/A-228-168-161N/A
3/31/2022N/A-206-160-155N/A
12/31/2021N/A-174-130-128N/A
9/30/202135-107-67-66N/A
6/30/202135-87-55-54N/A
3/31/202135-60-37-37N/A
12/31/202035-46-33-32N/A
9/30/2020N/A-73-64-63N/A
6/30/2020N/A-68-60-60N/A
3/31/2020N/A-62-57-57N/A
12/31/2019N/A-51-48-47N/A
9/30/2019N/A-41-35-34N/A
6/30/2019N/A-29-31-30N/A
3/31/2019N/A-18-20-19N/A
12/31/2018N/A-18-14-14N/A

アナリストによる今後の成長予測

収入対貯蓄率: SWTXは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 2.6% ) よりも高い成長率であると考えられます。

収益対市場: SWTX今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: SWTX今後 3 年以内に収益を上げることが予想されます。

収益対市場: SWTXの収益 ( 44.7% ) US市場 ( 8.9% ) よりも速いペースで成長すると予測されています。

高い収益成長: SWTXの収益 ( 44.7% ) 20%よりも速いペースで成長すると予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: SWTXの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘